NCT07114523

Brief Summary

Impacted mandibular third molars can cause various complications to the adjacent second molars, such as dental caries, periodontitis, or root resorption. These complications often progress silently and asymptomatically. A typical scenario involves a mesioangularly impacted third molar exerting pressure on the distal alveolar bone of the second molar, resulting in persistent food impaction that is difficult for patients to clean. Furthermore, the surgical removal of deeply impacted or severely angulated mandibular third molars often requires bone removal in the area adjacent to the second molar. These factors may exacerbate distal periodontal defects of the second molar, especially in individuals over the age of 25. This research focuses on evaluating the effectiveness of a new-generation collagen membrane in promoting healing after the extraction of impacted mandibular third molars in patients at risk of distal periodontal tissue damage to the second molars

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Dec 2024Mar 2027

Study Start

First participant enrolled

December 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

August 11, 2025

Status Verified

November 1, 2024

Enrollment Period

2.1 years

First QC Date

July 29, 2025

Last Update Submit

August 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Distal periodontal tissue status

    distal periodontal tissue status was assessed using variables of pocket depth

    preoperative (T0), 3rd moth after surgery (T3) and 6th month after surgery (T6)

Secondary Outcomes (1)

  • Distal bone level

    at the time of the end of surgery (T0'), 3rd month after surgery (T3), and 6th month after surgery (T6).

Other Outcomes (3)

  • Postoperative pain

    on the 1st, 3rd, 7th day after surgery

  • Postoperative swelling

    on the 1st, 3rd, 7th day after surgery

  • Soft tissue healing

    on the 7th day after surgery

Study Arms (2)

study

EXPERIMENTAL

apply collagen membrane on distal surface of second molar after third molar surgery

Procedure: collagen membrane

control

ACTIVE COMPARATOR

standard third molar surgery without any application

Procedure: third molar surgery

Interventions

collagen membrane apply to distal surface of second molar after third molar surgery

study

standard third molar surgery without any additional application

control

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 25 years or older.
  • Patients with mesioangular or horizontally impacted mandibular third molars. The highest point of mandibular third molars are lower than the occlusal surface of adjacent second molars (classified B, C according to Pell - Gregory's category).
  • Patients with symmetrical lower third molars on both sides with same classification according to Pell - Gregory's category. The difference of third molars inclination on both side is not more than 15°.
  • Patients with lower second molars on both sides have no cavities or fillings that affect the determination of the cemento-enamel junction.
  • Patients are explained, counseled clearly and sign their consent to participate in the study.

You may not qualify if:

  • Patients with coagulation or immune disorders.
  • Patients allergic to local anesthetics (Lidocaine 2% with Adrenaline 1:100,000) or any drugs used in the study.
  • Patients allergic to products or food derived from pigs.
  • Pregnant or breastfeeding patients.
  • Patients who smoke.
  • Patients with systemic conditions that contraindicate surgical procedures.
  • Patients with clinical or radiographic signs suggestive of tumors (benign or malignant) associated with or in proximity to the mandibular third molar.
  • Patients with missing mandibular second molars.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Medicine and Pharmacy at Ho Chi Minh city

Ho Chi Minh City, Vietnam

RECRUITING

Central Study Contacts

Phong Cu Lam, MD.DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This type of interventional study in dentistry is referred to as a split-mouth design. In this design, the intervention subjects have bilaterally symmetrical conditions within the oral cavity, allowing one side to serve as the intervention group while the contralateral side serves as the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer, clinical professor

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 11, 2025

Study Start

December 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

March 31, 2027

Last Updated

August 11, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations